» Articles » PMID: 2550995

Adenomatous Hyperplastic Nodules in the Cirrhotic Liver: Differentiation from Hepatocellular Carcinoma with MR Imaging

Overview
Journal Radiology
Specialty Radiology
Date 1989 Oct 1
PMID 2550995
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Differentiation of hepatocellular carcinomas from adenomatous hyperplastic nodules (AHNs) is important for the early and precise detection of hepatocellular carcinoma in the cirrhotic liver. For this purpose, the authors compared findings on magnetic resonance (MR) images of surgically resected AHNs (n = 7) with those of hepatocellular carcinoma (n = 47). AHNs were divided into two histologic groups: those without atypia (n = 5) and those with atypical hepatocytes or malignant foci (n = 2). All AHNs without atypia were hyperintense on T1-weighted spin-echo images and hypointense on T2-weighted spin-echo images relative to the surrounding liver. However, almost all hepatocellular carcinomas, except for two lesions with massive coagulation necrosis, were demonstrated as hyperintense on T2-weighted images. MR imaging may be useful in the differentiation of AHN without atypia from hepatocellular carcinoma in the cirrhotic liver.

Citing Articles

Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI.

Park S, Byun J, Hwang S Cancers (Basel). 2023; 15(5).

PMID: 36900153 PMC: 10000173. DOI: 10.3390/cancers15051361.


Differentiating malignant from benign hyperintense nodules on unenhanced T1-weighted images in patients with chronic liver disease: using gadoxetic acid-enhanced and diffusion-weighted MR imaging.

Moon J, Kim S, Choi S, Hwang J, Lee J, Lee J Jpn J Radiol. 2018; 36(8):489-499.

PMID: 29876721 DOI: 10.1007/s11604-018-0748-x.


Hepatic adenomatosis in liver cirrhosis.

Gordic S, Thung S, Roayaie S, Wagner M, Taouli B Eur J Radiol Open. 2017; 4:115-117.

PMID: 28932768 PMC: 5597816. DOI: 10.1016/j.ejro.2017.08.001.


Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Omata M, Cheng A, Kokudo N, Kudo M, Lee J, Jia J Hepatol Int. 2017; 11(4):317-370.

PMID: 28620797 PMC: 5491694. DOI: 10.1007/s12072-017-9799-9.


Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues.

Yoon J, Park J, Lee J Korean J Radiol. 2016; 17(1):7-24.

PMID: 26798212 PMC: 4720815. DOI: 10.3348/kjr.2016.17.1.7.